Somatostatin analogs modulate AIP in somatotroph adenomas: the role of the ZAC1 pathway

Harvinder S Chahal1, Giampaolo Trivellin, Chrysanthia A Leontiou

  • 1Centre for Endocrinology, Barts and the London School of Medicine, Queen Mary University of London, London EC1M 6BQ, United Kingdom.

Abstract

Insights

Aryl hydrocarbon receptor interacting protein (AIP) may mediate somatostatin analog effectiveness in sporadic somatotroph tumors via ZAC1. This finding could explain treatment resistance in patients with AIP mutations.

Area of Science:

  • Endocrinology
  • Molecular Biology
  • Oncology

Background:

  • Somatotroph adenomas with aryl hydrocarbon receptor interacting protein (AIP) mutations show reduced response to somatostatin analogs.
  • This suggests a potential role for AIP in mediating somatostatin analog efficacy.

Purpose of the Study:

  • To investigate the involvement of AIP in the mechanism of action of somatostatin analogs.
  • To explore the relationship between AIP, ZAC1, and somatostatin analog response in somatotroph tumors.

Main Methods:

  • Human study: 16-week lanreotide pretreatment versus no pretreatment in acromegaly patients (n=49).
  • In vitro study: GH3 cell line treated with octreotide or transfected with AIP-targeting siRNA/plasmids.
  • Measurements included hormone levels, tumor volume, AIP and somatostatin receptor expression, ZAC1 expression, and cell proliferation.

Main Results:

  • Lanreotide pretreatment significantly reduced GH, IGF-I, and tumor volume.
  • AIP immunostaining was higher in the lanreotide-pretreated group.
  • Octreotide increased AIP and ZAC1 expression in GH3 cells; AIP modulation affected ZAC1 levels and cell proliferation.
  • AIP mutations did not correlate with reduced somatostatin receptor staining.

Conclusions:

  • AIP appears to mediate somatostatin analog action through ZAC1 in sporadic somatotroph tumors.
  • This mechanism may underlie the limited efficacy of somatostatin analogs in patients with AIP mutations.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Glucagon-like Receptor Agonists01:24

Glucagon-like Receptor Agonists

Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by the...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Regulation of Food Intake01:30

Regulation of Food Intake

Short-term regulation of food intake primarily involves neural signals from the gastrointestinal (GI) tract, blood nutrient levels, and GI tract hormones. Communication between the gut and brain via vagal nerve fibers plays a significant role in evaluating the contents of the gut. Clinical studies have shown that protein ingestion produces a more prolonged response in these nerve fibers compared to an equivalent amount of glucose. Additionally, the activation of stretch receptors caused by GI...